Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients
Authors:
- Marc DecramerMDMarc Decramer
- François MaltaisFMFrançois Maltais
- Gregory FeldmanGFGregory Feldman
- Jean BrooksJBJean Brooks
- Stephanie HarrisSHStephanie Harris
- Rashmi MehtaRMRashmi Mehta
- Glenn CraterGCGlenn Crater
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 185 (2) , 393-399
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPDChest, 2012
- A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPDRespiratory Medicine, 2012
- Aclidinium bromide provides long-acting bronchodilation in patients with COPDPulmonary Pharmacology & Therapeutics, 2010
- The effect of tiotropium on exacerbations and airflow in patients with COPDEuropean Respiratory Journal, 2006
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2002
- The Spirometric Efficacy of Once-Daily Dosing With Tiotropium in Stable COPDChest, 2000
- Mechanisms for isolated volume response to a bronchodilator in patients with COPDJournal of Applied Physiology, 2000
- Spirometric Reference Values from a Sample of the General U.S. PopulationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?Thorax, 1993